Bao, Y., Ye, J., Liao, X., Chen, Z., Tu, X., Zheng, L., Wang, Q., Chen, K., Liu, T., Wei, Q. (2026). A phase II study evaluating the efficacy and safety of perioperative enfortumab vedotin plus toripalimab combined with endoscope-based kidney-sparing surgery for patients with high-risk upper tract urothelial carcinoma (WUTSUP-04-EV-JS001).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps905